Advertise on podcast: UroNurse

Join Vic Senese, RN, BSN, FAUNA, for a special edition of UroNurse, LIVE from Las Vegas at the Society of Urologic Nurses and Associates (SUNA) meeting! We're bringing you the excitement, camaraderie, professional connections, and behind-the-scenes atmosphere of one of the important gatherings for urology nursing professionals. From reconnecting with colleagues and sharing experiences to celebrating the people who make a difference in urologic healthcare, Las Vegas provides the perfect backdrop for this special UroNurse episode. 🌟 WHAT HAPPENS IN VEGAS? 📍 Live from Las Vegas: Experience the SUNA meeting through the eyes of a longtime urology nurse and educator. 👩‍⚕️ Urology Nursing Community: Celebrate the nurses, advanced practice providers, educators, and healthcare professionals dedicated to improving urologic care. 🤝 Networking & Connections: Discover the value of professional relationships, shared experiences, and collaboration within the urology community. 🎓 Education & Professional Growth: Celebrate ongoing learning, new ideas, and the commitment to advancing urology nursing practice. 🎲 A Little Vegas Fun: After all, what happens in Vegas stays in Vegas… unless Vic brings a camera! Whether you're a urology nurse, nurse practitioner, physician, medical assistant, healthcare educator, or someone passionate about urologic health, this special episode celebrates the people and experiences that make our professional community unique. ABOUT URONURSE UroNurse provides educational conversations, professional insights, and information for the urology healthcare community. Hosted and presented by Vic Senese, RN, BSN, FAUNA, a nationally recognized urology nurse, educator, and advocate, UroNurse connects healthcare professionals through digital education and shared experiences. 🔔 SUBSCRIBE TO URONURSE!Don't miss upcoming interviews, educational programs, and conversations covering urology nursing, clinical practice, patient education, and advances in urologic healthcare. 👉 Subscribe here: https://www.youtube.com/@UroNurse1 👍 Like this video, share it with your colleagues, and leave a comment: What's your favorite memory from a SUNA meeting? #SUNA #UrologyNursing #UroNurse #SUNAConference #Urology #NursingEducation #LasVegas #HealthcareProfessionals #NurseEducator #UrologicNursing The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

BCG is one of the most fascinating stories in modern urology. Originally developed as a vaccine against tuberculosis, Bacillus Calmette-Guérin eventually became an important immunotherapy for selected patients with non-muscle-invasive bladder cancer. In this edition of UroNurse News, Vic Senese, RN, BSN, FAUNA, takes you through The Story of BCG — from its development by Albert Calmette and Camille Guérin in the early 20th century to the landmark use of intravesical BCG for bladder cancer. BCG was developed from an attenuated strain of Mycobacterium bovis and became a tuberculosis vaccine. Researchers later discovered that BCG could stimulate immune responses against cancer. In 1976, Dr. Álvaro Morales and colleagues reported the use of BCG directly inside the bladder for recurrent superficial bladder tumors.  That discovery helped establish intravesical BCG as a major treatment for non-muscle-invasive bladder cancer. Subsequent clinical trials demonstrated reductions in bladder cancer recurrence, helping establish BCG as an important form of cancer immunotherapy.  In this episode, we explore: 🔹 The origins of BCG🔹 Albert Calmette and Camille Guérin🔹 How a TB vaccine became cancer immunotherapy🔹 Dr. Álvaro Morales and the landmark 1976 study🔹 Why BCG is placed directly into the bladder🔹 How BCG stimulates the immune system🔹 Why BCG remains important in bladder cancer treatment🔹 What happens when bladder cancer becomes BCG-unresponsive The story of BCG demonstrates how unexpected discoveries can transform medicine. Subscribe to UroNurse:Subscribe to the UroNurse YouTube channel The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

If you have a significantly enlarged prostate and medications or other treatments are no longer providing enough relief, your urologist may discuss simple prostatectomy as a treatment option for severe benign prostatic hyperplasia (BPH). But what is the difference between a robotic simple prostatectomy and an open simple prostatectomy? In this episode of UroPatient, hosted by Vic Senese, RN, BSN, FAUNA, and joined by co-host Laurie Atkinson, RN, FAUNA, we take a closer look at these two surgical approaches and explain what patients may want to know before discussing simple prostatectomy with their urologist. A simple prostatectomy removes the enlarged inner portion of the prostate that is causing urinary obstruction. It is different from a radical prostatectomy, which removes the prostate as part of prostate cancer treatment. In this episode, we discuss: • What a simple prostatectomy is• Why simple prostatectomy may be recommended for men with a very large prostate• The difference between robotic simple prostatectomy and open simple prostatectomy• How the two procedures are performed• The role of robotic-assisted surgery• Incisions and surgical access• Hospital recovery and length of stay• Urinary catheter considerations after surgery• Possible differences in pain and recovery• Bleeding and other potential complications• How urinary symptoms may improve after surgery• Recovery at home• When patients may return to normal activities• Questions to ask your urologist before choosing a surgical approach Robotic-assisted simple prostatectomy uses several small abdominal incisions and robotic surgical instruments controlled by the surgeon. The approach may offer advantages such as smaller incisions and potentially easier recovery for some patients. Open simple prostatectomy uses a larger incision to access the prostate. Although it is a more traditional surgical approach, it remains an important option for selected patients, particularly those with very large prostates or specific anatomical considerations. So, is robotic simple prostatectomy better than open surgery? There isn't one answer for every patient. The best approach depends on factors such as prostate size, anatomy, previous abdominal or prostate procedures, the surgeon's experience, available technology, overall health, and the patient's individual goals and preferences. The purpose of this episode is to help patients understand the conversation they should have with their urologist before making a treatment decision. If you or someone you know has BPH, an enlarged prostate, urinary obstruction, weak urine flow, urinary retention, or is considering prostate surgery, this episode can help you understand some of the terminology and questions surrounding simple prostatectomy. Hosted by Vic Senese, RN, BSN, FAUNA 👉 Subscribe to my UroNurse YouTube channel:https://www.youtube.com/@UroNurse1 simple prostatectomy, robotic simple prostatectomy, open simple prostatectomy, robotic vs open prostatectomy, BPH surgery, enlarged prostate surgery, benign prostatic hyperplasia, BPH treatment, prostate surgery, robotic prostate surgery, prostatectomy recovery, large prostate treatment, urinary obstruction, urinary retention, urology, urology nurse, UroPatient, Vic Senese #OpenProstatectomy #BPH #EnlargedProstate #BPHSurgery #ProstateSurgery #Urology #UroPatient #UroNurse #MensHealth #ProstateHealth The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

What are the best treatment options for benign prostatic hyperplasia (BPH) in 2026? And where does the innovative Optilume BPH Catheter System fit into the growing range of treatments available for men with an enlarged prostate? In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA, is joined by BPH expert Dean Elterman, MD, for an in-depth discussion about the evolving treatment landscape for BPH and lower urinary tract symptoms. BPH is one of the most common conditions affecting aging men and can cause urinary frequency, urgency, weak urinary stream, difficulty starting urination, incomplete bladder emptying, and nighttime urination. While medications such as alpha blockers and 5-alpha-reductase inhibitors remain important treatment options, today's patients have more choices than ever—including minimally invasive procedures and surgical therapies. In this discussion, we'll explore Optilume for BPH, how the technology works, which patients may be candidates, and how it compares with other contemporary BPH treatment options. We'll also discuss: • What is BPH and why does the prostate enlarge with age?• Common symptoms of an enlarged prostate• When medications may be appropriate• Alpha blockers and 5-alpha-reductase inhibitors• Phosphodiesterase-5 inhibitors such as tadalafil• Minimally invasive treatments for BPH• How the Optilume BPH procedure works• Potential benefits and limitations of Optilume• UroLift and other minimally invasive options• Rezūm water vapor therapy• Aquablation therapy• HoLEP and other laser procedures• TURP and traditional surgical treatment• How prostate size and anatomy influence treatment selection• Preserving sexual function and ejaculation when choosing a BPH procedure• Recovery, durability, and patient expectations• How physicians and patients can approach shared decision-making• What men should ask their urologist before choosing a BPH treatment OPTILUME FOR BPH Optilume represents an important development in minimally invasive BPH treatment. The technology combines mechanical dilation with delivery of the drug paclitaxel to the prostatic urethra. We'll discuss what that means for patients and how this approach fits into the broader BPH treatment landscape. WHICH BPH TREATMENT IS RIGHT FOR YOU? There is no single best BPH treatment for every man. The right choice can depend on prostate size, prostate anatomy, symptom severity, urinary retention, medications, bladder function, overall health, and the importance of preserving sexual and ejaculatory function. That's why understanding the differences between Optilume, UroLift, Rezūm, Aquablation, HoLEP, TURP, medications, and other BPH treatments is so important. Join Vic Senese, RN, BSN, FAUNA, and Dean Elterman, MD, as they examine where BPH treatment is heading and what today's patients should know before making a treatment decision. The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

Tadalafil: What Does It Treat Besides Erectile Dysfunction? When most people hear tadalafil, they think of erectile dysfunction—or ED. But tadalafil is used for more than helping with erections. In this episode of UroNurse News, host Vic Senese, RN, BSN, FAUNA, is joined by co-host Laurie Atkinson, RN, FAUNA, to explain the important medical uses of tadalafil and why this medication may be prescribed for conditions beyond sexual performance. Tadalafil is a PDE5 inhibitor that can affect blood flow and smooth muscle in different parts of the body. Depending on the dose and indication, tadalafil may be used to treat erectile dysfunction (ED), benign prostatic hyperplasia (BPH)and the urinary symptoms associated with an enlarged prostate. It is also approved for pulmonary arterial hypertension (PAH) under specific dosing and medical supervision. In this episode, Vic and Laurie discuss: • What tadalafil is and how it works• Tadalafil for erectile dysfunction• Tadalafil for benign prostatic hyperplasia (BPH)• How tadalafil may improve urinary symptoms associated with an enlarged prostate• Tadalafil and pulmonary arterial hypertension (PAH)• Why tadalafil can have effects beyond erections• Common side effects and important precautions• Why tadalafil should not be combined with nitrates• Why patients should discuss medications and health conditions with their healthcare professional• The difference between tadalafil dosing for different medical conditions If you've been prescribed Cialis or tadalafil and want to understand why, this episode provides a straightforward overview of the medication and its uses. Hosted by Vic Senese, RN, BSN, FAUNACo-host: Laurie Atkinson, RN, FAUNA Subscribe to the UroNurse YouTube channel for more urology education, men's health information, medication discussions, bladder health, prostate health, sexual health and the latest urology news: Subscribe to UroNurse on YouTube Keywords: tadalafil, tadalafil uses, Cialis, Cialis uses, erectile dysfunction, ED treatment, BPH, benign prostatic hyperplasia, enlarged prostate, BPH treatment, urinary symptoms, tadalafil for BPH, tadalafil for ED, pulmonary arterial hypertension, PAH, PDE5 inhibitors, men's health, prostate health, urology, urology nurse, UroNurse, Vic Senese, Laurie Atkinson. The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA, is joined by Matthew Galsky, MD, an internationally recognized expert in genitourinary oncology, to discuss the rapidly evolving role of immunotherapy in bladder cancerand how practice-changing advances are moving from clinical trials into everyday patient care. Bladder cancer treatment has entered a new era. Immune checkpoint inhibitors, antibody-drug conjugates, targeted therapies, and emerging treatment combinations are changing how clinicians approach patients with muscle-invasive bladder cancer (MIBC), metastatic urothelial carcinoma, and advanced bladder cancer. In this conversation, Dr. Galsky discusses important developments in bladder cancer immunotherapy and the implications for urology, oncology, and multidisciplinary patient care. The current role of immunotherapy in bladder cancerHow immune checkpoint inhibitors are changing treatment strategiesThe evolution of treatment for advanced and metastatic urothelial carcinomaPractice-changing clinical trial resultsHow new therapies are being incorporated into clinical practiceImmunotherapy before and after surgeryTreatment considerations for muscle-invasive bladder cancerAdvances in treatment for patients who are not candidates for traditional approachesThe expanding role of combination therapiesAntibody-drug conjugates and their impact on bladder cancer treatmentHow clinicians should think about rapidly emerging treatment optionsThe importance of multidisciplinary collaboration between urology, medical oncology, radiation oncology, and nursingWhat these advances mean for bladder cancer patients and their familiesWhat urology nurses and other healthcare professionals should know about the changing treatment landscapeThe future direction of bladder cancer research and immunotherapyFor decades, treatment options for advanced bladder cancer were relatively limited. Today, clinicians have an increasingly sophisticated range of systemic therapies and treatment combinations. Understanding these developments is particularly important for urology nurses, advanced practice providers, urologists, medical oncologists, and other healthcare professionals who care for patients throughout the bladder cancer journey. This episode provides an educational discussion of the science, clinical evidence, and evolving treatment strategies behind modern bladder cancer immunotherapy. Whether you are a healthcare professional looking to stay current on urothelial carcinoma treatment, a urology nurse following advances in oncology, or a patient seeking to better understand the rapidly changing bladder cancer treatment landscape, this discussion provides valuable perspective from an expert in genitourinary oncology. Hosted by Vic Senese, RN, BSN, FAUNA 🎙️ Guest: Matthew Galsky, MD Subscribe to the UroNurse YouTube channel for more interviews, clinical education, urology news, and discussions with leading experts in urologic healthcare: Subscribe to UroNurse on YouTube The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. Topics discussed include:Why this mattersKeywords

Can prostate artery embolization (PAE) provide an effective, minimally invasive treatment option for men with an enlarged prostate? In this episode, Vic Senese, RN, BSN, FAUNA, explores Prostate Artery Embolization (PAE) with Dr. Ayygari, as part of a myCME.com educational series on PAE. PAE is an increasingly important treatment option for men experiencing symptoms caused by benign prostatic hyperplasia (BPH), also known as an enlarged prostate. Unlike traditional prostate surgery, PAE is performed by an interventional radiologist using a catheter to selectively block blood flow to portions of the prostate. The goal is to reduce prostate volume and improve lower urinary tract symptoms (LUTS) associated with BPH. In this episode, we take a closer look at how prostate artery embolization works, how physicians identify the prostate arteries, and where PAE fits among today's treatment options for BPH. What is prostate artery embolization (PAE)?How PAE treats benign prostatic hyperplasia (BPH)How the prostate's blood supply affects the procedureHow physicians identify the prostate arteriesThe role of cone-beam CT during PAEHow embolization particles reduce blood flow to the prostateWhat happens to the prostate after embolizationPotential benefits of PAEPossible risks and complicationsPAE compared with traditional prostate proceduresPAE compared with medications for BPHWho may be an appropriate candidate for PAEWhat patients should ask their urologist and interventional radiologistThe evolving role of PAE in the treatment of LUTS and enlarged prostateProstate Artery Embolization is a minimally invasive procedure designed to reduce blood flow to the prostate. During the procedure, an interventional radiologist guides a small catheter through an artery—often beginning through the wrist or groin—and navigates to the arteries supplying the prostate. Tiny embolic particles are then delivered to selected prostate arteries. By reducing blood flow, the prostate can shrink over time, potentially improving urinary symptoms. One of the fascinating aspects of PAE is that prostate vascular anatomy varies from patient to patient. Advanced imaging, including cone-beam CT, can help physicians identify the appropriate vessels and confirm blood flow during the procedure. 🔎 Topics discussed include:🩺 What is PAE? *The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

Voiding Trial: What’s the BEST Way to Perform It? Survey Says! What is the best way to perform a voiding trial after catheter removal? Should you use the fill-and-pull method, allow the bladder to fill naturally, measure the post-void residual (PVR), or follow another approach? Survey says... there may be more than one way to do it! In this episode, Vic Senese, RN, BSN, FAUNA, explores the important question of how healthcare professionals perform and evaluate a voiding trial, also known as a trial without catheter (TWOC). From bladder filling techniques to determining whether a patient has successfully passed the trial, this episode examines common approaches and the variation that exists in clinical practice. A voiding trial is frequently performed after urinary catheter removal, including following urologic procedures, surgery, episodes of urinary retention, and other situations where clinicians need to determine whether a patient can safely and effectively empty their bladder. 🔹 What a voiding trial or trial without catheter (TWOC) is🔹 Why a voiding trial is performed🔹 The difference between a retrograde fill-and-pull voiding trial and spontaneous bladder filling🔹 How much fluid may be instilled during a bladder-filled voiding trial🔹 What measurements may be used to evaluate successful bladder emptying🔹 The role of voided volume and post-void residual (PVR)🔹 Why there is variation in voiding-trial protocols🔹 Important factors that may influence whether a patient passes or fails a voiding trial🔹 Why standardized protocols can be valuable in clinical practice🔹 What the survey reveals about how healthcare professionals approach voiding trials 👍 LIKE this video if you found the discussion helpful! 🔔 SUBSCRIBE for more urology education:Subscribe to the UroNurse YouTube Channel Hosted by Vic Senese, RN, BSN, FAUNA, bringing practical urology education, clinical discussions, expert insights, and healthcare conversations to urology professionals and others interested in the field. The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. In This Episode, You'll Learn:What Is a Voiding Trial?Why Does the Method Matter?

An elevated PSA can be alarming—but it doesn't always mean prostate cancer. Before recommending a prostate biopsy, there are several important clinical steps that can improve diagnostic accuracy, reduce unnecessary procedures, and help patients make informed decisions. In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA, reviews the essential evaluation every clinician should consider after discovering an elevated PSA. Learn how to confirm an abnormal PSA, identify reversible causes of elevation, evaluate patient risk factors, understand the role of PSA density and PSA kinetics, determine when prostate MRI is appropriate, and recognize when additional biomarker testing may help guide clinical decision-making. This evidence-based discussion also explores shared decision-making with patients, current best practices, and practical tips that can help clinicians avoid unnecessary biopsies while identifying patients who may truly benefit from further evaluation. Whether you're a urology nurse, nurse practitioner, physician assistant, primary care provider, resident, medical student, or urologist, this episode provides practical guidance you can apply in everyday clinical practice. Causes of an elevated PSAConfirming an abnormal PSA resultRepeating PSA before biopsyDigital rectal examination (DRE)PSA densityPSA velocity and PSA kineticsRisk factors for prostate cancerFamily history and genetic riskMultiparametric prostate MRIMRI before prostate biopsyBiomarker testing (4Kscore, PHI, ExoDx and others)Active surveillance considerationsShared decision-makingCurrent prostate cancer evaluation guidelinesReducing unnecessary prostate biopsiesBest practices in prostate cancer detectionIf you enjoy evidence-based urology education designed for healthcare professionals, please subscribe to the UroNurse channel and turn on notifications so you never miss our latest episodes. Subscribe here: https://www.youtube.com/@UroNurse1 Hosted and presented by Vic Senese, RN, BSN, FAUNA #Urology #PSA #ProstateCancer #ProstateBiopsy #MRI #ProstateMRI #UroNurse #NursingEducation #UrologyNurse #PrimaryCare #Urologist #ProstateHealth #CancerScreening #4Kscore #PHI #ExoDx #EvidenceBasedMedicine #MedicalEducation #ContinuingEducation #Healthcare The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. Topics Covered

Welcome to UroNurse, hosted by Vic Senese, RN, BSN, FAUNA, where healthcare professionals and patients discover the latest innovations transforming urology. In this exclusive interview, Vic is joined by Dr. Diane Newman, Chief Clinical Officer, and Stuart Hart, MD, MBA, MS, Founder & CEO, to introduce UrologyHealth.com—the first virtual urology practice, a groundbreaking digital health platform created by urology experts and backed by more than 50 years of medical science. As healthcare continues to evolve, virtual care is becoming an essential part of delivering accessible, evidence-based medical services. In this conversation, you'll learn how UrologyHealth.com is designed to connect patients with expert urologic care through innovative digital technology while maintaining high clinical standards. What makes UrologyHealth.com the first virtual urology practiceHow telehealth is transforming access to urologic careThe vision behind this innovative digital health platformHow decades of medical science support the platform's clinical approachWhich patients may benefit from virtual urology servicesThe role of technology in improving patient education and outcomesHow virtual care complements traditional office-based urologyFuture trends in digital healthcare and urologyWhether you're a urologist, nurse practitioner, physician assistant, urology nurse, primary care provider, healthcare administrator, or patient interested in the future of medicine, this discussion offers valuable insights into how virtual care is reshaping urology. Don't miss this fascinating conversation with two leaders helping redefine how patients receive specialized urologic care. Featured Guests: Dr. Diane Newman – Chief Clinical OfficerStuart Hart, MD, MBA, MS – Founder & CEOHosted by:Vic Senese, RN, BSN, FAUNA If you enjoy interviews featuring the latest innovations in urology, healthcare technology, and patient care: ✅ Like this video✅ Subscribe for weekly urology news and expert interviews✅ Share this video with your colleagues✅ Leave your questions and comments below Subscribe to my channel:https://www.youtube.com/@UroNurse1 #Urology #Telehealth #VirtualCare #DigitalHealth #UrologyHealth #UroNurse #VicSenese #DianeNewman #StuartHart #HealthcareInnovation #UrologyNursing #PatientCare #MedicalTechnology #Telemedicine #HealthcareLeadership #FutureOfHealthcare #UrologyEducation #NursingEducation #MedicalPodcast #HealthcareTechnology The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. In this episode you'll discover:

Genital psoriasis is a common yet frequently underdiagnosed condition that can significantly affect a patient's physical comfort, emotional well-being, intimate relationships, and overall quality of life. Because many patients feel embarrassed to discuss symptoms, healthcare professionals must proactively recognize, assess, and manage this challenging condition with compassion and confidence. Join host Vic Senese, RN, BSN, FAUNA, for an engaging educational discussion featuring renowned dermatology experts David Cotter, MD and Naiem Issa, MD. Together, they explore the latest evidence-based approaches to diagnosing and treating genital psoriasis while emphasizing patient-centered communication and individualized care. *The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

Discover how biological age testing, artificial intelligence (AI), and precision medicine are revolutionizing the future of preventive healthcare in this compelling episode of UroNurse. Hosted by Vic Senese, RN, BSN, FAUNA, this educational interview features longevity medicine expert Gregory Burzynski, MD, who explains how understanding the biology of aging can help identify disease risk earlier, personalize treatment, and improve long-term health outcomes. Unlike your chronological age, your biological age reflects how your body is actually functioning at the cellular level. Learn how cutting-edge biomarkers, epigenetic (DNA methylation) testing, inflammation markers, metabolic health assessments, and advanced laboratory testing are helping physicians evaluate the aging process more accurately than ever before. Dr. Burzynski discusses the fascinating connection between aging biology and cancer pathways, revealing how many of the same biological processes—including chronic inflammation, cellular senescence, mitochondrial dysfunction, oxidative stress, impaired DNA repair, and immune system decline—contribute to both aging and the development of cancer. Understanding these shared mechanisms may lead to earlier detection and more effective prevention strategies. The conversation also explores how AI-driven early disease detection is transforming modern medicine. Artificial intelligence can analyze enormous amounts of clinical, imaging, laboratory, and genomic data to identify subtle patterns that may predict disease years before symptoms develop. These advances are helping clinicians transition from reactive healthcare to proactive, personalized prevention. You'll also learn about the exciting future of personalized preventive medicine, where healthcare decisions may be tailored to an individual's genetic profile, biological age, lifestyle, and health risks. From customized screening schedules to targeted interventions and longevity-focused care, the next generation of medicine aims to keep people healthier for longer. Whether you're a healthcare professional, patient, caregiver, or simply interested in healthy aging, cancer prevention, and the latest medical innovations, this episode offers valuable, evidence-based insights into one of the fastest-growing fields in medicine. To learn more about Dr. Gregory Burzynski's longevity practice, visit Restor Longevity Clinic at https://restorlongevityclinic.com. • What biological age testing measures and why it matters• Biological age vs. chronological age• How epigenetics influences aging and disease risk• Why aging and cancer share common biological pathways• The role of chronic inflammation in aging and cancer• How AI is improving early disease detection• Precision medicine and individualized healthcare strategies• Emerging technologies that may reshape preventive medicine• Practical steps toward healthier aging and longevity If you enjoy expert interviews covering urology, oncology, preventive medicine, longevity science, and healthcare innovation, be sure to subscribe for future episodes. Subscribe to my channel: https://www.youtube.com/@UroNurse1 #BiologicalAge #Longevity #HealthyAging #ArtificialIntelligence #AIHealthcare #PrecisionMedicine #CancerPrevention #CancerResearch #Epigenetics #EarlyDetection #PreventiveMedicine #LongevityMedicine #GregoryBurzynski #VicSenese #UroNurse #HealthInnovation #DNA #Inflammation #PersonalizedMedicine #FutureOfMedicine The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. In this episode you'll discover:

Discover how rapid molecular diagnostic testing is transforming modern urology care in this informative episode hosted by Vic Senese, RN, BSN, FAUNA, joined by Dr. Steven Goldberg, Chief Medical Officer at HealthTrackRx. Learn how next-morning infectious disease results are helping healthcare providers make faster, more accurate treatment decisions that can improve patient outcomes, reduce unnecessary antibiotic use, and streamline clinical workflows. In this discussion, Vic and Dr. Goldberg explore the growing role of advanced molecular diagnostics in urology, including how cutting-edge testing technologies are changing the way urinary tract infections (UTIs), complicated infections, antimicrobial resistance, and other urologic conditions are identified and managed. The episode also highlights the importance of integrating rapid diagnostic testing into everyday clinical practice to support antibiotic stewardship and improve patient-centered care. Topics covered include:• Rapid molecular diagnostic testing in urology• Next-morning infectious disease testing results• Advanced UTI diagnostics and detection• Antibiotic stewardship in urology practice• Molecular testing integration into clinical workflows• Improving patient outcomes through faster diagnosis• Emerging innovations in infectious disease diagnostics• Precision medicine in urologic healthcare• Clinical efficiency and workflow optimization• Future trends in urology diagnostics Whether you are a urology nurse, physician, advanced practice provider, infection prevention specialist, healthcare administrator, or student, this episode provides valuable insights into the future of diagnostic technology and its impact on patient care. Subscribe to my channel at UroNurse YouTube Channel for more urology news, education, interviews, and clinical updates hosted by Vic Senese, RN, BSN, FAUNA. *The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.

Welcome to Episode 208 of UroNurse! In this milestone episode, host Vic Senese, RN, BSN, FAUNA, is joined by expert guest speaker Leann McLaughlin, Uro-Oncology Clinical Nurse Specialist (CNS), to dive deep into the current landscape of prostate cancer screening and prostate biopsy protocols in Europe. Prostate cancer remains one of the most prevalent malignancies in men globally, but the clinical approach to early detection, PSA screening, and biopsy criteria varies significantly across borders. European urologic practices—frequently guided by the European Association of Urology (EAU) guidelines—have paved the way for innovative screening strategies, including risk-stratified screening, widespread utilization of pre-biopsy multiparametric MRI (mpMRI), and a significant clinical shift from transrectal (TRUS) to transperineal prostate biopsies to minimize sepsis risks. Whether you are a urology nurse, nurse practitioner, physician assistant, urologist, or healthcare student, this comprehensive discussion delivers evidence-based insights to help you understand international standards and advance your clinical practice. 🔍 What You'll Learn in This Episode: European Screening Frameworks: How European countries approach population-based vs. opportunistic PSA screening. The Role of Pre-Biopsy mpMRI: How the European model integrates advanced imaging to avoid unnecessary biopsies and improve precision. Transrectal vs. Transperineal Biopsy: Analyzing the European shift toward transperineal access to drastically lower infection and complication rates. Risk Stratification Models: Using risk calculators and biomarkers alongside PSA levels to optimize patient selection for biopsy. The CNS Perspective in Uro-Oncology: How Clinical Nurse Specialists in Europe manage patient counseling, anxiety, and post-procedure care pathways. Don't miss this milestone episode packed with real-world clinical education, comparative healthcare insights, and actionable knowledge for the entire urological care team. If you found this clinical breakdown valuable, please give this video a thumbs up, leave your questions in the comments below, and share it with your healthcare colleagues! 👉 Subscribe to my channel: UroNurse YouTube Channel🌐 Visit our website for resources & contact hours: UroNurse.com #ProstateCancer #ProstateBiopsy #UrologyNursing #UroNurse #ProstateScreening #UroOncology #MedicalEducation #NursingPodcast #EAUguidelines #MensHealth The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions. 🔔 Support the Channel

Can artificial intelligence help healthcare professionals educate patients more effectively? In this episode of UroNurse, host Vic Senese, RN, BSN, FAUNA explores how NotebookLM is changing the way urology nurses, advanced practice providers, physicians, and healthcare educators create patient education materials. Discover how NotebookLM can transform trusted clinical guidelines, research articles, patient handouts, and office protocols into easy-to-understand educational resources while keeping information grounded in your own uploaded sources. Learn practical ways AI can improve patient understanding, increase efficiency, reduce repetitive work, and help create personalized educational materials that support better clinical outcomes. In this episode you'll learn: What NotebookLM is and how it worksWhy AI is becoming an essential tool in healthcare educationCreating patient-friendly summaries from complex medical informationDeveloping FAQs, discharge instructions, and procedure explanationsSaving time while maintaining educational qualityBest practices for using AI responsibly in urologyThe importance of reviewing AI-generated content before sharing with patientsReal-world applications for clinics, hospitals, and outpatient urology practicesWhether you're a urology nurse, nurse practitioner, physician assistant, physician, educator, or healthcare administrator, this episode provides practical insights into integrating artificial intelligence into your patient education workflow. Artificial intelligence isn't replacing healthcare professionals—it empowers them to communicate more effectively, improve patient understanding, and spend more time delivering compassionate, personalized care. Subscribe to my channel: https://www.youtube.com/@UroNurse1 #AI #ArtificialIntelligence #NotebookLM #Urology #UrologyNurse #PatientEducation #HealthcareAI #NursingEducation #DigitalHealth #ClinicalEducation #HealthcareTechnology #MedicalEducation #UroNurse #VicSenese #FAUNA #NurseEducation #HealthTech #PatientCommunication #GoogleNotebookLM #UrologyPractice The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.